NICE backs use of new treatment for multiple myeloma
Sanofi's Sarclisa gets the final green light for use by the NHS with funding from the CDF
26th November 2020
Sanofi's Sarclisa gets the final green light for use by the NHS with funding from the CDF
26th November 2020
Delivery of vaccine doses to EU could begin by early 2021
26th November 2020
Tremfya is a first-in-class treatment for the disease, shown to improve disease measures and quality of life
26th November 2020
Chancellor Rishi Sunak hands out extra £3 billion to NHS and £14.6 billion in funding for R&D
26th November 2020
New report conducted by Imperial College London researchers and Philips UK highlights issues within the NHS
25th November 2020
Deal will focus on developing small molecules against a number of diseases
25th November 2020
Survey from The Royal Pharmacy Society shows impact of pandemic on pharmacists’ mental health
25th November 2020
Shot will be evaluated in pregnant mothers and their newborn infants
25th November 2020
Omecamtiv mecarbil and AMG 594 rights transitioned back to biotech
24th November 2020
Positive recommendation follows initial rejection in September
24th November 2020
Less-frequent, fixed-dose use approved for two cancer indications
24th November 2020
MenQuadfi approved for vaccination in individuals 12 months of age or older
24th November 2020
R&D spending in the sector last year represents an eight-year high
23rd November 2020
Lead programme will focus on developing therapies for Duchenne muscular dystrophy
23rd November 2020
Health leaders respond to reported £3bn funding boost
23rd November 2020